Quest Diagnostics falls on Q1 outlook headwinds, reaffirms FY guidance

 Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather conditions during the period and also provided long-term outlook.

For Q1 2025, the company expects that "worse-than-anticipated weather" during the period will create a headwind to revenue of about $25M and to EPS of approximately $0.10.

It anticipates long-term revenue growth at a 4-5% CAGR and adjusted EPS growth at a 7-9% CAGR beyond 2025.

The company also  reaffirmed its guidance for full year 2025.

According to consensus, Q1 EPS is expected to be $2.20 per share, while revenue is expected to be $2.65B.

For the full year, Street estimates EPS to be $9.71 per share and revenue to be $10.78B.

https://www.msn.com/en-us/money/companies/quest-diagnostics-falls-on-q1-outlook-headwinds-reaffirms-fy-guidance/ar-AA1Bf32u?ocid=finance-verthp-feeds